Why Did Novo Nordisk Contribute This Money To ATHN?

As a company, Novo Nordisk has a leading position within hemostasis management.  Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers.  ATHN is grateful that Novo Nordisk perceives our mission as a worthwhile cause and one way to fulfill its social responsibility to the community we all serve.